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artery disease. However, there is limited data on the subsequent hospitalizatons
and related direct health care costs among patients with pre-existing CKD under-
going percutaneous coronary intervention (PCI). We aimed to compare the rates
and costs of cardiac-related hospital readmissions following PCI in patients with
and without pre-existing CKD. METHODS: Direct health care costs were estimated
from 12,998 patients enrolled in the Melbourne Interventional Group (MIG) registry,
who underwent PCI between April 2004 and October 2010. Only individuals with
data on cardiovascular-related hospitalizations and medication use at 12-month
follow-up were included. Individual patient-procedures were assigned unit costs
based on published (DRG) data from the National Hospital Cost Data Collection for
Admissions in Victoria, Australia (2008-2009) and the Australian Pharmaceutical
Benefit Scheme schedule (2011-2012). A ‘bottom-up’ costing approach was used.
Costs relating to the index procedure and in-hospital complications were excluded.
Bootstrap linear regression was used to estimate the association between direct
medical costs and CKD categories, adjusting for age, gender and relevant
comorbidities. RESULTS: Excess cardiac-related readmissions occurred among pa-
tients with estimated glomerular filtration rate (eGFR)30 ml/min/1.73m2 (“severe
CKD or dialysis”, N330; 35%), compared to eGFR: 30-60 ml/min/1.73m2 (“moderate
CKD”, N2,648; 28%) or patients with eGFR60 ml/min/1.73m2(“referent group”,
N10,020; 24%). Adjusted mean (95%CI) total follow-up costs were significantly
higher in patients with severe CKD or dialysis [$AUD 2,206 ($AUD 1,148 - 3,688)].
CONCLUSIONS: Patients with severe CKD/dialysis undergoing PCI procedures in-
curred the highest mean direct health care costs at 12-month follow-up, compared
to those with better renal function. Hospitalization accounted for the majority of
these expenditures. Data gathered from this study have the potential to inform
policy makers of the likely economic impact of CKD in the context of invasive
treatment of CAD.
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OBJECTIVES: Surgery is common after a hip fracture. Two surgical options are
arthoplasty (AR) (i.e., hip replacement) or internal fixation (IF) (i.e., fixing the pa-
tient’s hip). Previous research suggests that AR is less costly than IF because IF
failure rate is high. This retrospective cohort study compared medical costs be-
tween IF and AR in patients with hip fractures of the femoral neck in a large US
population.METHODS: Patients50 years with IF or AR performed within 7 days of
a hip femoral neck fracture occurring between 7/1/2002 and 1/31/2010 were iden-
tified from the Marketscan database. Details on the specific location of the fracture
line within the femoral neck were not available. All patients had continuous insur-
ance coverage for 6 months prior to (pre-period) and 60 days following (post-period)
the surgery date (index date). Patients were followed from surgery date up to 18
months or until death, end of continuous enrollment, or end of study period (3/31/
2010), whichever came first. Generalized linear models on costs were used to adjust
different patient demographic and clinical characteristics. RESULTS: A total of
41,789 patients (mean age 80 years) were identified (60% IF and 40% AR patients).
Post-period mean monthly costs were similar between the two cohorts ($4344 for IF
vs. $4401 for AR, p0.339). Costs were the highest in the first month when the
surgery occurred and the IF cohort had lower cost than the AR cohort ($22,707 vs.
$25,646, p0.001). No statistically significant differences were found in the multi-
variate adjusted total mean monthly costs. The AR cohort had slightly higher in-
patient costs ($2642 for AR vs. $2469 for IF, p0.001) but lower outpatient costs
($1463 for AR vs. $1653 for IF, p0.001). CONCLUSIONS: In this large population,
both IF and AR interventions result in significant and similar health care costs.
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OBJECTIVES: Minimally Invasive Spinal Surgery (MIS) aim at minimizing muscle
trauma, reducing blood loss, decreasing postoperative pain, reducing surgery du-
ration and length of stay in hospital (LoS), and accelerate resuming normal activi-
ties for the patient. The objective of this study is to determine and compare the
resource consumption associated with OS vs. MIS in patients with degenerative
spinal disorder treated with a short construct. METHODS: This study was realized
in two French hospitals: one public and one private hospital, in which the learning
curve could be considered completed. To map the patient flow and estimate re-
source utilization, the clinical pathways of patients treated with open and MIS
spinal instrumentation were defined through interviews with medical staff. The
2009 French Hospitalization Costs Database (ENCC) updated with 2012 DRG tariffs,
was used to estimate the unit costs where differences were significant: 1) operating
room (OR), 2) LoS, 3) blood consumption. Costs were compared between both path-
ways (OS vs. MIS), in order to calculate the mean difference of costs. RESULTS: In
both hospitals MIS was associated with less resource use especially during surgery
and post-surgery episodes. This is mainly due to shorter OR time, LoS and less
blood loss. In the public case, 40% decrease in surgery time was observed, 38%
reduction in LoS and 100% decrease in blood consumption. In the private hospital,
28% decrease in surgery time, 41% reduction in LoS and 100% decrease in blood
consumption. The mean total costs saving associated with MIS corresponds to
1,469€ in the public hospital; and 652€ in the private hospital. CONCLUSIONS: MIS
potentially shortens operating and recovery time, decreases blood consumption,
and consequently reduces direct medical costs of hospital stays. This reduction
may offset the upfront investment (e.g. instrumentation). The findings are consis-
tent with published literature.
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OBJECTIVES: Osteoporotic vertebral compression fractures (OVCFs) are associated
with increased morbidity and mortality and with reduction in QoL. Vertebral aug-
mentation has been shown to be effective for treating these fractures. The associ-
ation between treatment and survivorship was analyzed in the Medicare Popula-
tion (Edidin 2010). Moreover, cost comparisons of kyphoplasty (BKP) and
vertebroplasty (VP) suggest that initial hospital costs are higher for BKP (Mehio
2011), while another study has reported cost effectiveness of BKP compared to VP
(Edidin 2012) Extensions of these analyses are necessary to verify the results for the
German setting. The purpose of the present study was to examine the overall
survival and treatment costs from a third payer perspective for OVCF patients
treated by VP or BKP. METHODS: To address the research questions claims, data of
a major health insurance fund (2.4 million insurants in 2011) were used. Groups
were established by propensity score matching adjusting for gender, age and over-
all comorbidity. For the matched OVCF-patients in the dataset (2006-2010) costs
were analyzed as well as survival was estimated by the Kaplan-Meier method.
RESULTS: A total of 598 newly diagnosed OVCF-patients who underwent vertebral
augmentation were identified from the data. After adjustment, 298 patients re-
mained. BKP-patients had a higher 60-month adjusted survival rate of 66.7%, com-
pared to 58.7% for VP-patients (p0.68). Cumulative 4-year mean overall costs
following the first diagnosis were lower for the BKP-cohort (VP: 42,510€ vs. BKP:
39,014€). Initially higher costs were mainly driven by costs for surgical treatment.
However, considerable pharmacy costs in VP-patients outweighed the primordially
lower inpatient costs. Major differences were found in costs for pain killers. (ATC
N02; VP: 3,321€ vs. BKP: 2,224€). CONCLUSIONS: Results suggest higher overall
survival for BKP-patients compared to VP-patients. Total costs were found to be
lower after 4 years for patients who received BKP due to lower pharmacy costs in
the long run.
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OBJECTIVES: Scoliosis is defined as a lateral deviation of the spine. Although most
of the curves are small to moderate and never necessitate intervention, some of
these curves progress and will require surgical interventions. These procedures are
associated with significant health care resources consumption. The objective of
this study was to assess the economic impact of scoliosis from a Canadian health
care system perspective. METHODS: Using a subset of 125,000 patients covered by
the provincial drug reimbursement program (Régie de l’assurance maladie du Qué-
bec (RAMQ)), a retrospective prescription and medical claims analysis was per-
formed. Patients who received a diagnosis of scoliosis (ICD9  737.3) from January
2003 to December 2011 were included in the analysis. Annual health care resources
utilization and costs were estimated for patients with scoliosis. Surgical proce-
dures associated with scoliosis were identified using the procedure codes found in
the RAMQ database. The costs and the resources utilization associated with the
surgical procedures were estimated over a one-year period from 30 days preceding
to 335 days following the surgery. RESULTS: Between January 2003 and December
2011, 523 individuals of the sample population received a diagnosis of scoliosis,
with a higher proportion of females (70.6%). Among these patients, 22 (4.2%) re-
quired at least one scoliosis surgery, for a total of 94 procedures. Most surgeries
were correction of the scoliosis via a posterior approach using Luke or Cotrel-
Dubousset segmental instrumentation (84% of all the procedures). The mean an-
nual medical cost associated with scoliosis was $4,865 while it was $29,777 for
patients who had a surgery. Annual medication cost were $1,178 for all patients
with scoliosis and $1,546 for patients who had a surgery. CONCLUSIONS: The eco-
nomic impact of scoliosis in Canada is substantial, especially when a surgical in-
tervention is required.
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OBJECTIVES: Anastomotic leaks after colorectal surgeries can lead to complica-
tions, and considerably increase medical resource use and cost. This study quan-
tified the incidence, and clinical and economic burden of anastomotic leaks follow-
ing colorectal surgeries in the US. METHODS: Premier Perspective database was
used to identify patients having a set of colorectal surgeries between Jan 2008 to
Dec 2010. The colorectal surgeries included colectomy, hemicolectomy, and rec-
tum resection. The anastomotic leak event was defined by re-operation, re-anas-
tomosis, stent, colostomy, drainage, and abscess within 30-day window following
the index colorectal surgeries. The index surgery and re-intervention were identi-
fied by ICD-9 procedure codes, CPT codes and Standard Charge Master codes. This
study entails two analyses: (1) the overall incidence rate of 30-day anastomotic
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leak; (2) the differences in LOS, readmission, post-operative infection, and total
inpatient costs between the patients with anastomotic leaks and those without
leaks. Chi square test and T test were used to compare outcomes between two
cohorts, before and after employing propensity-score matching technique based
on a series of baseline covariates. Generalized linear model was also conducted.
RESULTS: A total of 6174 (6.18%) patients with colorectal surgeries had 30-day
anastomotic leak during 2008-2010.The patients with anastomotic leak had 1.3
times higher 30-day readmission (p0.01), and 1.9 times higher postoperative in-
fection (p0.01) compared to the patient without anastomotic leak. Anastomotic
leak incurred additional LOS of 7.3 days and additional average hospital cost of
$24,399 for index hospitalization alone. When the extra burden of readmission was
added, the average incremental LOS increased to 9.5 days, and the average incre-
mental hospital costs increased to $28,597. CONCLUSIONS: Anastomotic leaks in
colorectal surgeries increase clinical and economic burden by 0.5 to 1.8 times in
terms of additional readmission, postoperative infection, LOS, and hospital costs.
The results underscore the potential advantage of cost reduction by preventing the
anastomotic leaks after colorectal surgeries.
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OBJECTIVES: To encourage quality improvements and assess high expenditures
for patients with coronary artery bypass graft (CABG) surgery and hospital quality
in Turkey. METHODS: Using the Turkish National Health Insurance Database
(2009-2011), CABG surgery patients were identified using the appropriate Interna-
tional Classification of Diseases Tenth Revision Clinical Modification codes. High-
cost cardiac surgery patients had annual health care costs in the top 20% post-
surgery. The empirical Bayes approach was used to combine mortality rates with
hospital volume for quality index, weighing observed mortality according to esti-
mation reliability, with the remaining weight placed on hospital volume. The rela-
tionship between hospital quality and high-cost payments was assessed using
chi-square tests. RESULTS: Total annual health care payments for 20,126 identified
CABG patients were approximately a70 million. High-cost patients incurred 31% of
the total expenditures. Although disease severity did not differ for patients across
hospitals, those in the lowest quintile cared for 25% of high-costs surgery patients,
compared with only 18% in the highest quality hospitals (p0.0001). a4M in asso-
ciated cost savings was calculated for patients shifting from low- to high-quality
hospitals. CONCLUSIONS: Results imply that hospital quality improvements can
reduce costs and improve morbidity and mortality rates in Turkey.
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OBJECTIVES: Estimate the cost of a adhesiolysis (surgical procedure to remove
adhesions abdomen or pelvis) in the Brazilian private health care system.
METHODS: Using a claims database, 1585 patients were classified according to
code Brazilian Private HealthCare System (TUSS code) and observed between Jan-
uary/2009 to December/2011 all costs associated with the surgical procedure to
remove adhesions abdomen or pelvis were considered across seven major catego-
ries: materials, medications, procedure, exams, alimentation, rates and medicinal
gases. RESULTS: Out of the 1585 patients that used the private health care system
and made a adhesiolysis in a period of 36 months, 93% are women and the majority
between 30 -34 years old (27,22%) with an expenditure of about R$ 13millhon with
average cost , per patient of R$ 8.228,39 were hospitalized for 4 days. The 56% of
patients remove the adhesion after a surgical abdominal or pelvic and them ex-
penditure 51% was due to procedure and materials, followed by rates (21%), med-
ication (20%), alimentation (3%), exams (3%) and medicinal gases (2%).
CONCLUSIONS: . Procedure spending of adhesiolysis could have been avoided if
there was the use of barreir.
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OBJECTIVES: A recent pilot study suggests the current NHS HRG Tariff for parathy-
roidectomy (PTX) (£2,710 and £2,209 in patients with and without complications
respectively) is not representative of the true costs of surgery in patients with
secondary hyperparathyroidism (SHPT). This study aims to describe the health
care resources used to manage patients undergoing PTX, for SHPT, and estimate
the cost in a UK tertiary care centre. METHODS: Resource use was identified by
combining data from the PROTON renal database, and routine hospital data, for all
adults undergoing PTX for SHPT at Cardiff and Vale University Health Board from
2000-2008. Data were supplemented by a questionnaire completed by clinicians in
the Cardiff centre. Costs were obtained from the NHS reference costs, British Na-
tional Formulary and published literature. These costs were applied for the follow-
ing periods: pre-surgical, surgical, peri-surgical, and post-surgical to calculate the
total cost of PTX. RESULTS: The analysis included 124 patients (mean age 51.0, SD
13.8). Patients’ underlying renal disease had a wide range of causes, undergoing
renal replacement therapy for a mean of 7.3 years, SD 7.0 prior to PTX. The main
costs identified included the surgical stay (average £4,100, SD £2,338; mean stay 5.6
days, SD 7.4), yearly post-discharge outpatient surveillance (£735, £147 and £147, in
the first, second and third years respectively) and medications (£733, £650 and £643,
in the first, second and third years respectively). Average total cost for the pre-
surgical, surgical, and peri-surgical periods amounted to £4,968 (SD £2,361).
CONCLUSIONS: This analysis demonstrates that the cost of PTX surgery in SHPT
exceeds the current NHS HRG tariffs for PTX.
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OBJECTIVES: Cardiac surgery can result in renal impairment necessitating hemo-
filtration (HF; dialysis) which prolongs the length of therapy (LOT), days in the
intensive care unit (ICU) and is associated with an overall higher mortality. The
decision to initiate HF-therapy is currently made on increased plasma creatinine
levels, a relatively late marker (peaking days after a potentially reversible renal
dysfunction). The novel urine marker NGAL (neutrophil-gelatinase-associated li-
pocalin) measures the acute structural damage and identifies the need for HF
within hours with high accuracy. METHODS: Based on data collected in 2005-2009,
we prospectively included NGAL in an algorithm to modify the management of
HF-therapy in 2010. Changes in incidence of HF and LOT, all costs associated with
routine NGAL-testing and ICU stay (direct and indirect) as well as the economic
impact were analysed. RESULTS: A total of 528 patients were operated with no
statistical difference in numbers, case mix, risk scores and outcomes to the previ-
ous years. The expected number of patients with HF was 45.3 with an average LOT
of 7.7 days (2005-2009). Introduction of NGAL-testing added costs of € 60.00/patient
(€ 31.680/year). Although € 2047,50/day could be realized through public health
refunding, the fixed associated costs were € 3249,70/patient/day [€ 892,52 for all
supplies to operate the HF (Prismaflex, Gambro, Germany) and € 2357,18 for insti-
tutional ICU expenditure (incorporating personnel costs)] resulting in a deficit of €
1202,19/day with, and € 751,58 without HF operating. Using the new marker, only 32
patients required treatment with HF for a mean of 5.5 days and earlier initiation (1.1
days) in 2010 (p0,001). A total of 41.6 days of treatment in ICU (occupancy) were
avoided with savings of € 44.153,16. CONCLUSIONS: Routine NGAL testing and
consecutive changes in management reduced the number of HF-therapies, lengths
of therapy and ICU stay in our institution and proved to be cost-saving.
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OBJECTIVES: Minimally invasive surgery techniques (MIS) for lumbar spine fusion
allow surgical treatment of back and leg pain while aiming at minimizing tissue
injury and accelerating patient recovery. The objective of this study was to esti-
mate the cost-effectiveness of MIS compared to open surgery (OS) for the treatment
of degenerative lumbar spinal conditions in a UK setting. METHODS: Resources,
costs and differences in Health Related Quality of Life (HRQoL) after MIS and OS
were based on a literature review or derived from other public sources. Resources
included were: staff and operating room, surgical equipment, consumables, blood
loss, surgical drainage, duration of hospitalization and post-operative complica-
tions. In the base case it was assumed that the surgeons hadn’t reached the top of
the learning curve. The cost-effectiveness was expressed as the incremental cost
per QALY gained using a time horizon of two years after surgery. The costs included
the total direct medical cost associated with either procedure and the utility gain
was estimated from the Swedish national spinal registry data. RESULTS: Modeling
showed that MIS was the dominant strategy vs. open surgery yielding both cost
savings and improved HRQoL. Cost savings were driven mainly by shorter length of
hospital stay, less blood loss and fewer complications. The total cost-saving was
£639 per procedure with a small improvement in HRQoL (0.04 QALY gain after 2
years). CONCLUSIONS: MIS may be a dominant treatment option compared to OS
for spinal lumbar fusion in a UK setting. Lower costs and increased HRQoL in the
MIS group compensate for potential higher upfront costs of MIS implants and
equipment. Future analyses should consider the inclusion of indirect costs as the
majority of the patient population is below age 65 and will potentially return to
work.
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NODE DISSECTION IN EARLY BREAST CANCER STAGING
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OBJECTIVES: As part of the information needed for recommendations making, we
aimed to compare the cost of systematic axillary lymph node dissection and sen-
tinel lymph node biopsy –with axillary dissection only if the sentinel node contains
metastases-, with or without intra-operative histological examination. METHODS:
Unit costs collected in a French national study were included in a model simulating
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